A report on Sheena McCormack's presentation "PrEP: What's happening in Europe and the world in general"
This presentation outlined the current status of PrEP uptake around the world. It touched on some of the challenges and outlined some of the anticipated new medications and new modes of delivery of PrEP.
The overwhelming message is that PrEP using TDF/FTC either daily or on demand is effective in averting new HIV infections ( PREVENIR study 85 HIV infections averted; EPIC N.S.W. 31.5% decline in recent infections compared with previous year, 25% reduction attributed to PrEP; Soho London clinic 80% decline in HIV cases since 2015).